Abstract

DIABETES TECHNOLOGY SOCIETY
DTM 2O18
18th annual diabetes technology meeting Agenda
07:00 Continental Breakfast
Workshop A: Adherence to Treatment
Panel 1: Technology for Determining Adherence
08:00
Koji Sode, PhD
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Bithika Thompson, MD
Mayo Clinic, Scottsdale, Arizona
08:05
Deborah Greenwood, PhD, RN, BC-ADM, CDE, SAADE
Deborah Greenwood Consulting, Sacramento, California
08:20
Jane Seley, DNP, MPH, MSN, GNP, BC-ADM, CDE, CDTC, FAAN
New York Presbyterian / Weill Cornell Medicine, New York, New York
08:35
David Ahn, MD
Mary & Dick Allen Diabetes Center at Hoag, Newport Beach, California
08:50
University of Colorado Barbara Davis Center for Diabetes, Aurora, Colorado
09:05
09:35
Panel 2: Technology for Increasing Adherence
09:55
Gabriel Bitton, PhD
Insuline Medical, Petah Tikva, Israel
Sammy Choi, MD
Womack Army Medical Center, Fort Bragg, North Carolina
10:00
Mark Clements, MD, PhD
Children's Mercy Hospital, Kansas City, Missouri
10:15
Nisha Subramanian, MBA
McKinsey & Company, Summit, New Jersey
10:30
Jennal Johnson, FNP, MS
Eli Lilly, Indianapolis, Indiana
10:45
Eda Cengiz, MD
Yale University, New Haven, Connecticut
11:00
11:30
07:00
Workshop B: Diabetes Technology in the Hospital
Panel 1: New Uses for Established Hardware
08:00
Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, Maryland
Garry Steil, PhD
Boston Children’s Hospital, Boston, Massachusetts
08:05
Leslie Landree, PhD
FDA, Silver Spring, Maryland
08:20
William Clarke, PhD, MBA, DABCC
Johns Hopkins University, Baltimore, Maryland
08:35
Mark Rice, MD
Vanderbilt University, Nashville, Tennessee
08:50
Curtiss B. Cook, MD
Mayo Clinic, Scottsdale, Arizona
09:05
09:35
Panel 2: Novel Technologies
09:55
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand
Greg Garcia, BS
Healthcare Sector Coordinating Council, Washington, DC
10:00
Elias Spanakis, MD
University of Maryland, Baltimore, Maryland
10:15
Roman Hovorka, PhD
University of Cambridge, Cambridge, United Kingdom
10:30
Michael Taborn, BSEE
Intel Corporation, Phoenix, Arizona
10:45
Tim West, BS
GuidePoint Security, St. Louis, Missouri
11:00
11:30
Workshop C: The Future of Self-Monitoring of Blood Glucose (SMBG)
Panel 1: Maximizing Technology
12:30
Heather C. Kuiper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia
Rosemary Oshinsky, MSN, RN, CDE
Sibley Memorial Hospital, Johns Hopkins University, Washington, DC
12:35
Timothy S. Bailey, MD, FACE
AMCR Institute, Escondido, California
12:50
Deanna Bogner, MT (ASCP)
Baptist Health System, San Antonio, Texas
13:05
Robert Cohen, MD
University of Cincinnati, Cincinnati, Ohio
13:20
Ed Krisiunas, MPH
WNWN International, Burlington, Connecticut
13:35
14:05
Panel 2: Emerging Trends
14:25
Robert Burk, MD
Albert Einstein College of Medicine, Bronx, New York
Kong Chen, PhD MSCI
NIDDK/National Institutes of Health, Bethesda, Maryland
14:30
Corinne Fantz, PhD, DABCC, FACB
Roche Diagnostics, Indianapolis, Indiana
14:45
Martin Lange, MBA
Ascensia, Basel, Switzerland
15:00
Susana Patton, PhD, CDE
University of Kansas, Kansas City, Kansas
15:15
Ishan Barman, PhD
Johns Hopkins University, Baltimore, Maryland
15:30
16:05
16:15–18:30
18:30–20:00
Workshop D: Novel Hardware
Panel 1: Implanted Sensors
12:30
Alexander Fleming, MD
Kinexum, Harpers Ferry, West Virginia
Jisun Yi, MD
FDA, Silver Spring, Maryland
12:35
Mark Arnold, PhD
University of Iowa, Iowa City, Iowa
12:47
William Markle, MBA
GlySens, San Diego, California
12:59
Chris Hanson, MS
Theranova, San Francisco, California
13:11
Fotios Papadimitrakopoulos, PhD
University of Connecticut, Storrs, Connecticut
13:23
Andreas Pfützner, MD, PhD
Lifecare AS, Bergen, Norway
13:35
14:05
Panel 2: Insulin Pumps
14:25
Robert Gabbay, MD, PhD
Joslin Diabetes Center, Harvard University, Boston, Massachusetts
14:30
Roy Beck, MD, PhD
Jaeb Center for Health Research, Tampa, Florida
John Pickup, MD, PhD
King’s College London School of Medicine, London, United Kingdom
15:10
Aiman Abdel-Malek, PhD
Insulet Corporation, San Diego, California
15:25
Ian Welsford, PhD
EOFlow, San Jose, California
15:40
Del Lawson, PhD
3M Medical Materials & Technologies, Maplewood, Minnesota
15:55
16:05
16:15–18:30
18:30–20:00
07:00
Session 1: Healthcare Information Technology
08:00
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California
University of California, San Francisco, San Francisco, California
08:05
Jeffrey Shuren, MD, JD
FDA, Silver Spring, Maryland
08:30
Andrew Bremer, MD, PhD
NIDDK/National Institutes of Health, Bethesda, Maryland
Dorian Liepmann, PhD
University of California, Berkeley, Berkeley, California
08:30
Tom Lawry, BS
Microsoft, Redmond, Washington
08:50
Ron Ribitzky, MD
R&D Ribitzky, Newtown, Massachusetts
Session 2: CGM-Based Outcome Metrics
9:10
Guillermo Arreaza-Rubin, MD
NIDDK/National Institutes of Health, Bethesda, Maryland
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California
University of California, San Francisco, San Francisco, California
9:10
Richard Bergenstal, MD
International Diabetes Center, St. Louis Park, Minnesota
Boris Kovatchev, PhD
UVA Center for Diabetes Technology, Charlottesville, Virginia
Roy Beck, MD, PhD
Jaeb Center for Health Research, Tampa, Florida
Courtney Lias, PhD
FDA, Silver Spring, Maryland
David Maahs, MD, PhD
Stanford University, Palo Alto, California
10:50
Session 3: Regulation of Diabetes Technology
11:15
Alberto Gutierrez, PhD
NDA Partners LLC, Bethesda, Maryland
Dominique Shelton Leipzig, JD
Perkins Coie, Los Angeles, California
11:15
Marc Breton, PhD
UVA Center for Diabetes Technology, Charlottesville, Virginia
11:30
Naomi Schwartz, BS
FDA, Silver Spring, Maryland
11:40
Alain Silk, PhD
FDA, Silver Spring, Maryland
11:50
Bradley Merrill Thompson, JD
Epstein Becker & Green, P.C., Washington, DC
12:05
12:20
Session 4: Artificial Pancreas in Type 1
13:20
Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania
Moshe Phillip, MD
Schneider Children’s Medical Center, Petah Tikva, Israel
13:20
13:25
Guillermo Arreaza-Rubin, MD
NIDDK/National Institutes of Health, Bethesda, Maryland
13:37
Daniel Finan, PhD
JDRF, New York, New York
13:49
Stacey Anderson, MD
UVA Center for Diabetes Technology, Charlottesville, Virginia
14:01
Eyal Dassau, PhD
Harvard University, Cambridge, Massachusetts
14:13
14:18
Trang Ly, MBBS, FRACP, PhD
Insulet Corporation, Billerica, Massachusetts
14:30
Eric Renard, MD, PhD
Montpellier University Hospital, Montpellier, France
14:42
15:05
Session 5: CEO Discussion: Artificial Pancreas in Type 2
15:30
David Kerr, MD, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California
15:30
Jeffrey Brewer, BA
CEO, Bigfoot Biomedical, Milpitas, California
Marcel Gmuender, JD
Global Head of Roche Diabetes Care, Basel, Switzerland
Hooman Hakami, BBA
Executive Vice President and Group President, Medtronic Diabetes, Northridge, California
Patrick Sullivan, MBA
President and CEO, Insulet Corporation, Billerica, Massachusetts
16:30–18:30
18:30–20:00
07:00
Session 6: Novel Insulins
8:00
Gerald Grodsky, PhD
University of California, San Francisco, San Francisco, California
John Nolan, MD
European Diabetes Forum, Dublin, Ireland
8:05
8:10
Activity Detection and Activity Level Categorization in Free-Living Subjects with Type 1 Diabetes
Divya Choudhary
Harvard University, Cambridge, Massachusetts
08:25
Bruce Bode, MD, FACE
Atlanta Diabetes Associates, Atlanta, Georgia
08:45
Lutz Heinemann, PhD
Science & Co., Düsseldorf, Germany
09:05
Eric Zijlstra, PhD
Profil, Neuss, Germany
09:25
Simon H. Friedman, PhD
University of Missouri, Kansas City, Missouri
09:45
10:05
Session 7: Digital Diabetes Data Science
10:30
Jorge Bondia, PhD
Universitat Politecnica de Valencia, Valencia, Spain
Andrea Facchinetti, PhD
University of Padova, Padova, Italy
10:30
Boris Kovatchev, PhD
UVA Center for Diabetes Technology, Charlottesville, Virginia
10:50
Moshe Phillip, MD
Schneider Children’s Medical Center, Petah Tikva, Israel
11:10
Andrew Bremer, MD, PhD
NIDDK/National Institutes of Health, Bethesda, Maryland
11:30
Noel Burtt, BS
Broad Institute, Cambridge, Massachusetts
11:50
12:10
Session 8: Hot Topics in Diabetes Technology
13:10
Andreas Pfützner, MD, PhD
Lifecare AS, Bergen, Norway
Victor Schneider, MD
NASA, Washington, DC
13:15
Matthias Hebrok, PhD
University of California, San Francisco, San Francisco, California
13:35
Simon Heller, MD
The University of Sheffield, Sheffield, United Kingdom
13:55
Session 9: Infusion Sets
14:05
Andrea Bell-Vlasov, PhD
FDA, Silver Spring, Maryland
Ulrike Klueh, PhD
Wayne State University, Detroit, Michigan
14:05
Lutz Heinemann, PhD
Science & Co., Düsseldorf, Germany
14:20
Matthias Heschel, PhD
Convatec, Copenhagen, Denmark
14:30
Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania
14:40
Bob Cargill, PhD
Pacific Diabetes Technology, Portland, Oregon
14:50
Eric Renard, MD, PhD
Montpellier University Hospital, Montpellier, France
15:05
15:15
Session 10: Technology to Improve Accuracy of Needle Sensor CGMs
15:40
Jesper Fleischer, PhD
Aarhus University, Aarhus, Denmark
John Pickup, MD, PhD
King’s College London School of Medicine, London, United Kingdom
15:40
Marc Taub, PhD
Abbott Diabetes Care, Alameda, California
15:52
Peter Simpson, PhD
Dexcom, San Diego, California
16:04
Andrea Varsavsky, PhD
Medtronic Diabetes, Los Angeles, California
16:16
Mihailo Rebec, PhD
WaveForm Technologies, Wilsonville, Oregon
16:28
Session 11: Live Demonstration
16:40
John Pickup, MD, PhD
King’s College London School of Medicine, London, United Kingdom
16:40
Michael Abramoff, MD, PhD
IDx-DR
University of Iowa, Iowa City, Iowa
17:00
